Seres Therapeutics, Inc. (MCRB) is a publicly traded Healthcare sector company. As of May 21, 2026, MCRB trades at $7.79 with a market cap of $73.50M and a P/E ratio of -1.45. MCRB moved +1.88% today. Year to date, MCRB is -49.57%; over the trailing twelve months it is -7.04%. Its 52-week range spans $6.53 to $29.98. Analyst consensus is buy with an average price target of $22.00. Rallies surfaces MCRB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Seres Therapeutics, Inc. (MCRB) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. MCRB moved +1.88% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $7.79 |
| Market Cap | $73.50M |
| P/E Ratio | -1.45 |
| EPS | $-5.18 |
| Dividend Yield | 0.00% |
| 52-Week High | $29.98 |
| 52-Week Low | $6.53 |
| Volume | 1 |
| Avg Volume | 0 |
| Revenue (TTM) | $1.15M |
| Net Income | $-46.90M |
| Gross Margin | 0.00% |
1 analysts cover MCRB: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $22.00.